TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -9.75%10.16B | 14.22%24.08B | 16.23%11.26B | 4.30%21.08B | -8.64%9.69B | 31.51%20.21B | 93.85%10.6B | 58.07%15.37B | 35.04%5.47B | 18.52%9.72B |
Operating income | -9.75%10.16B | 14.22%24.08B | 16.23%11.26B | 4.30%21.08B | -8.64%9.69B | 31.51%20.21B | 93.85%10.6B | 58.07%15.37B | 35.04%5.47B | 18.52%9.72B |
Cost of sales | 7.36%-8.81B | -16.09%-20.68B | -14.07%-9.5B | -4.67%-17.82B | 5.27%-8.33B | -40.03%-17.02B | -104.76%-8.8B | -56.08%-12.16B | -30.92%-4.3B | -16.72%-7.79B |
Operating expenses | 7.36%-8.81B | -16.09%-20.68B | -14.07%-9.5B | -4.67%-17.82B | 5.27%-8.33B | -40.03%-17.02B | -104.76%-8.8B | -56.08%-12.16B | -30.92%-4.3B | -16.72%-7.79B |
Gross profit | -22.73%1.35B | 4.03%3.39B | 29.50%1.75B | 2.35%3.26B | -25.05%1.35B | -0.76%3.19B | 53.94%1.81B | 66.04%3.21B | 52.59%1.17B | 26.38%1.93B |
Selling expenses | 4.74%-224.31M | -11.06%-532.17M | -22.30%-235.46M | -11.37%-479.18M | 6.16%-192.53M | -12.76%-430.24M | -33.96%-205.17M | -5.17%-381.55M | -3.01%-153.16M | -23.85%-362.81M |
Administrative expenses | -0.87%-287.91M | -0.65%-561.43M | -8.21%-285.43M | -16.19%-557.79M | -8.15%-263.77M | 5.91%-480.06M | 10.00%-243.89M | 1.74%-510.23M | -6.71%-270.99M | -5.00%-519.27M |
Research and development expenses | 10.72%-410.12M | -21.44%-904.47M | -25.61%-459.36M | -11.54%-744.82M | 18.91%-365.7M | -30.24%-667.78M | -96.01%-451.01M | -29.82%-512.74M | -42.65%-230.09M | -17.04%-394.96M |
Impairment and provision | -878.88%-809.45M | -38.67%-295.11M | -22.02%-82.69M | -596.96%-212.81M | -133.90%-67.77M | 207.66%42.82M | 79.67%-28.97M | 36.04%-39.78M | -9,653.22%-142.53M | -8.99%-62.19M |
-Other impairment is provision | -878.88%-809.45M | -38.67%-295.11M | -22.02%-82.69M | -596.96%-212.81M | -133.90%-67.77M | 207.66%42.82M | 79.67%-28.97M | 36.04%-39.78M | -9,653.22%-142.53M | -8.99%-62.19M |
Special items of operating profit | -5.11%185.27M | -18.69%269.21M | 3.56%195.25M | 90.70%331.09M | 93.76%188.54M | 145.73%173.62M | -32.47%97.3M | -253.82%-379.7M | -19.30%144.1M | -38.59%246.85M |
Operating profit | -121.70%-192.05M | -14.31%1.37B | 35.69%885.13M | -12.42%1.6B | -33.04%652.32M | 31.54%1.83B | 87.18%974.24M | 64.83%1.39B | 35.21%520.49M | 12.19%842.51M |
Financing income | 12.52%62.9M | 5.62%123.09M | 6.34%55.9M | 68.99%116.53M | 71.59%52.57M | -8.77%68.96M | -25.66%30.63M | -6.50%75.59M | -9.71%41.21M | -43.82%80.84M |
Financing cost | -1.18%-401.14M | -29.68%-763.56M | -50.41%-396.45M | -152.17%-588.81M | -94.45%-263.58M | 17.45%-233.5M | 30.56%-135.55M | 44.76%-282.87M | 31.99%-195.22M | 18.85%-512.03M |
Share of profits of associates | 74.95%-473K | 96.85%-2.64M | 27.33%-1.89M | -175.34%-83.85M | -123.95%-2.6M | -799.91%-30.45M | -36.39%10.85M | -171.21%-3.38M | 418.64%17.05M | -70.08%4.75M |
Earning before tax | -197.80%-530.76M | -30.27%727.71M | 23.70%542.69M | -36.04%1.04B | -50.16%438.71M | 38.51%1.63B | 129.49%880.17M | 183.13%1.18B | 161.19%383.53M | 48.71%416.08M |
Tax | 705.47%183.63M | 71.84%-112.47M | 90.66%-30.33M | -70.08%-399.38M | -172.21%-324.88M | 28.19%-234.81M | -39.89%-119.35M | -423.79%-327M | -271.78%-85.31M | -479.07%-62.43M |
After-tax profit from continuing operations | -167.75%-347.13M | -4.50%615.24M | 350.09%512.36M | -53.88%644.21M | -85.04%113.84M | 64.13%1.4B | 155.12%760.82M | 140.65%851.06M | 51.76%298.22M | 31.47%353.65M |
After-tax profit from non-continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 202.29%63.96M |
Earning after tax | -167.75%-347.13M | -4.50%615.24M | 350.09%512.36M | -53.88%644.21M | -85.04%113.84M | 64.13%1.4B | 155.12%760.82M | 103.79%851.06M | 147.40%298.22M | 102.26%417.61M |
Minority profit | -40.10%181.6M | -4.22%519.72M | 57.47%303.19M | 564.84%542.61M | 406.48%192.54M | 704.09%81.62M | 1,003.21%38.02M | 149.33%10.15M | 46.76%-4.21M | -966.72%-20.58M |
Shareholders should account for profits from continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 29.92%367.43M |
Shareholders should account for profits from non-continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 195.11%70.76M |
Profit attributable to shareholders | -352.78%-528.73M | -5.99%95.52M | 365.75%209.17M | -92.28%101.6M | -110.89%-78.71M | 56.41%1.32B | 139.00%722.8M | 91.91%840.91M | 135.45%302.43M | 110.26%438.19M |
Basic earnings per share | -352.34%-0.323 | -6.45%0.058 | 366.67%0.128 | -92.29%0.062 | -110.86%-0.048 | 56.42%0.804 | 138.92%0.442 | 91.79%0.514 | 137.18%0.185 | 109.38%0.268 |
Diluted earnings per share | -352.34%-0.323 | -6.45%0.058 | 366.67%0.128 | -92.29%0.062 | -110.86%-0.048 | 56.42%0.804 | 138.92%0.442 | 91.79%0.514 | 137.18%0.185 | 109.38%0.268 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Tianshi Hong Kong Certified Public Accountants Limited | -- | Tianshi Hong Kong Certified Public Accountants Limited | -- | Tianshi Hong Kong Certified Public Accountants Limited | -- | Tianshi Hong Kong Certified Public Accountants Limited | -- | Tianshi Hong Kong Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.